Aktienanalyse wird geladen …
ARE · NYSE · Real Estate (REIT) · USA
51,39 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3,03 Mrd. | -1,43 Mrd. | -8,44 $ | 170,31 Mio. | 0,8 Mio · 0,5 % | 68,7 % | -47,2 % | — | 0,24 $ | 4,68 $ |
| 2024 | 3,12 Mrd. | 322,95 Mio. | 1,80 $ | 172,07 Mio. | 1,2 Mio · 0,7 % | 70,2 % | 10,4 % | 8,74 $ | 0,35 $ | 5,19 $ |
| 2023 | 2,89 Mrd. | 103,64 Mio. | 0,54 $ | 170,91 Mio. | 1,6 Mio · 0,9 % | 70,2 % | 3,6 % | 9,54 $ | 0,48 $ | 4,96 $ |
| 2022 | 2,59 Mrd. | 521,66 Mio. | 3,18 $ | 161,66 Mio. | 1,1 Mio · 0,7 % | 69,8 % | 20,2 % | 8,01 $ | 0,36 $ | 4,72 $ |
| 2021 | 2,11 Mrd. | 571,25 Mio. | 3,82 $ | 147,46 Mio. | 0,9 Mio · 0,6 % | 70,5 % | 27 % | 6,85 $ | 0,33 $ | 4,48 $ |
| 2020 | 1,89 Mrd. | 770,96 Mio. | 6,01 $ | 126,49 Mio. | 0,8 Mio · 0,7 % | 71,9 % | 40,9 % | 6,98 $ | 0,34 $ | 4,24 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge |
|---|---|---|---|---|---|
| Q2 2026 | 662,78 Mio. | -72,78 Mio. | -0,43 $ | 170,72 Mio. | -11 % |
| Q1 2026 | 671,02 Mio. | 361,65 Mio. | 2,12 $ | 170,87 Mio. | 53,9 % |
| Q4 2025 | 754,41 Mio. | -1,08 Mrd. | -6,35 $ | 170,39 Mio. | -143,3 % |
| Q3 2025 | 751,94 Mio. | -232,75 Mio. | -1,37 $ | 170,18 Mio. | -31 % |
| Q2 2025 | 762,04 Mio. | -107 Mio. | -0,63 $ | 170,14 Mio. | -14 % |
| Q1 2025 | 758,16 Mio. | -8,94 Mio. | -0,05 $ | 170,52 Mio. | -1,2 % |
| Q4 2024 | 788,95 Mio. | -62,25 Mio. | -0,37 $ | — | -7,9 % |
| Q3 2024 | 791,61 Mio. | 167,95 Mio. | 0,98 $ | 172,06 Mio. | 21,2 % |
Alexandria Real Estate Equities Shares Fall After JPMorgan Downgrade
Jefferies Adjusts Price Target on Alexandria Real Estate Equities to $46 From $47, Keeps Hold Rating
JPMorgan Downgrades Alexandria Real Estate Equities to Underweight From Neutral, Price Target is $56
Is the Options Market Predicting a Spike in Alexandria Real Estate Equities Stock?
Evercore ISI Adjusts PT on Alexandria Real Estate Equities to $59 From $57, Keeps Outperform Rating
Goldman Sachs Adjusts PT on Alexandria Real Estate Equities to $59 From $54, Keeps Neutral Rating
Alexandria Real Estate Equities Stock: Is ARE Underperforming the Real Estate Sector?
Alexandria Real Estate Equities Insider Sold Shares Worth $849,073, According to a Recent SEC Filing
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust that owns, operates, and develops specialized campuses for research-driven tenants. The company focuses on collaborative megacampus environments designed for life science, agtech, and advanced technology users, offering laboratory, office, and innovation space tailored to scientific discovery and commercialization. Its properties are concentrated in major innovation clusters such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria Real Estate Equities, Inc. serves a diverse tenant base that includes biotechnology and pharmaceutical companies, academic and medical research institutions, government-related organizations, and technology-focused businesses. The company plays a central role in providing real estate infrastructure for sectors that depend on highly specialized facilities, supporting research, development, and cross-disciplinary collaboration within the innovation economy.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest ARE und jede andere Aktie unbegrenzt.